Trial record 1 of 97 for:    Stratify 1
Previous Study | Return to List | Next Study

JC-Virus (JCV) Antibody Program (STRATIFY-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01070823
Recruitment Status : Completed
First Posted : February 18, 2010
Last Update Posted : October 5, 2016
United BioSource Corporation
Elan Pharmaceuticals
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : June 2012